Orthofix Medical (NASDAQ:OFIX) reported fourth-quarter 2025 results that management said capped a year of “meaningful operational progress,” highlighted by continued momentum in Bone Growth Therapies ...
Before we begin, please note that our remarks include forward-looking statements. All statements other than those of ...
LONDON, UK / ACCESS Newswire / February 10, 2026 / Proxymity, the digital investor communications platform, today ...